Prof. Oh Young Bang | Neuroscience | Best Researcher Award

SAMSUNG MEDICAL CENTER | SOUTH KOREA

Prof. Oh Young Bang is a renowned neurologist and biomedical researcher, currently serving as a Professor in the Department of Neurology at Samsung Medical Center, affiliated with Sungkyunkwan University School of Medicine, Seoul, Korea. He also holds a professorship at the Samsung Advanced Institute for Health Sciences and Technology. In addition to his academic roles, he is the CEO of S&E Bio, a pioneering biotech company focused on stem cell-derived exosome therapies targeting incurable diseases. His contributions have significantly advanced both the clinical and translational neuroscience domains.

Professional profile👤

Google Scholar

ORCID

Strengths for the Awards✨

Professor Oh Young Bang stands as a global leader in the field of neurology, particularly in stroke research, neuroimaging, and stem cell-derived exosome therapy. His current roles—Professor at Samsung Medical Center, Sungkyunkwan University, and CEO of S&E Bio—showcase his academic and translational research excellence. His groundbreaking work bridges the gap between basic science and real-world clinical solutions, with a strong focus on biomarkers, risk factors, and novel therapies for incurable neurological diseases.

Bang’s publication record is exceptionally strong, with over 300 peer-reviewed SCI/SCIE papers, numerous book chapters, and participation in international multicenter clinical trials. His ability to move seamlessly from preclinical models to human trials emphasizes translational impact. His work on mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) has gained global recognition, notably for enhancing neuroplasticity post-stroke and showing scalable production methods.

Moreover, his editorial contributions to prestigious journals such as Stroke, J Stroke, and Cerebrovascular Disease, along with being Editor-in-Chief of Precision and Future Medicine, underline his thought leadership in the scientific community. The 30 patents he holds are a testament to his innovation-driven mindset and industry-aligned contributions.

🎓 Education

While specific degrees and institutions are not listed in the provided data, it is evident that Professor Bang’s academic foundation is firmly rooted in neurology and neuroscience, having led to his dual professorships and executive role in biotechnology. His advanced training has equipped him to bridge clinical neurology with innovative biotech applications.

💼 Experience

Professor Bang has built an illustrious career with extensive experience in clinical neurology, stroke research, and regenerative medicine. He actively leads preclinical and clinical stroke programs, emphasizing neuroimaging, biomarkers, risk factor analysis, and stem cell therapy. With a prolific output of over 300 SCI/SCIE-indexed articles, numerous book chapters, and 30 patents, he has played a pivotal role in global research and innovation. His leadership in international clinical trials and his contributions as a keynote speaker at global neurology and biotechnology conferences underscore his global impact.

🔬 Research Interests On Neuroscience

Professor Bang’s research focuses on stroke mechanisms, neuroimaging techniques, stem cell therapy, and biomarkers of neurological diseases. A notable aspect of his work includes advancing mesenchymal stem cell (MSC) therapy through extracellular vesicles, as well as developing scalable production methods for clinical applications. His research also investigates cancer-related thrombosis, arterial remodeling, and the neurovascular interface, making him a thought leader in translational neuroscience.

🏆 Awards & Editorial Roles

Though specific honors are not detailed, Professor Bang’s reputation is validated by his leadership roles in multiple top-tier journals. He served on the editorial boards of:

• Stroke (2010–2015)

• Journal of Stroke (since 2013)

• Journal of Clinical Neurology (2006–2014)

• Cerebrovascular Disease (2016–2019)
  Additionally, he was Editor-in-Chief of Precision and Future Medicine (2018–2022). His selection to these prestigious roles highlights his scientific influence and recognition in neurology and biomedical science.

📚 Selected Publications

• Randomized assessment of rapid endovascular treatment of ischemic stroke
  Authors: M Goyal, AM Demchuk, BK Menon, M Eesa, JL Rempel, J Thornton, et al.
  Year: 2015
  Citations: 7,247

• Autologous mesenchymal stem cell transplantation in stroke patients
  Authors: OY Bang, JS Lee, PH Lee, G Lee
  Year: 2005
  Citations: 1,489

• A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke
  Authors: JS Lee, JM Hong, GJ Moon, PH Lee, YH Ahn, OY Bang
  Year: 2010
  Citations: 941

• Collateral flow predicts response to endovascular therapy for acute ischemic stroke
  Authors: OY Bang, JL Saver, SJ Kim, GM Kim, CS Chung, B Ovbiagele, KH Lee, et al.
  Year: 2011
  Citations: 660

• Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial
  Authors: MD Hill, M Goyal, BK Menon, RG Nogueira, RA McTaggart, AM Demchuk, et al.
  Year: 2020
  Citations: 609

• Longitudinal changes of resting-state functional connectivity during motor recovery after stroke
  Authors: C Park, WH Chang, SH Ohn, ST Kim, OY Bang, A Pascual-Leone, YH Kim
  Year: 2011
  Citations: 567

• Impact of collateral flow on tissue fate in acute ischaemic stroke
  Authors: OY Bang, JL Saver, BH Buck, JR Alger, S Starkman, B Ovbiagele, D Kim, et al.
  Year: 2008
  Citations: 479

• Stroke statistics in Korea: part I. Epidemiology and risk factors
  Authors: KS Hong, OY Bang, DW Kang, KH Yu, HJ Bae, JS Lee, JH Heo, SU Kwon, et al.
  Year: 2013
  Citations: 442

• Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis
  Authors: BCV Campbell, CBLM Majoie, GW Albers, BK Menon, N Yassi, G Sharma, et al.
  Year: 2019
  Citations: 407

• Early neutrophilia is associated with volume of ischemic tissue in acute stroke
  Authors: BH Buck, DS Liebeskind, JL Saver, OY Bang, SW Yun, S Starkman, LK Ali, et al.
  Year: 2008
  Citations: 404

• Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data
  Authors: L San Román, BK Menon, J Blasco, M Hernández-Pérez, A Dávalos, et al.
  Year: 2018
  Citations: 397

• Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke
  Authors: OY Bang, JL Saver, SJ Kim, GM Kim, CS Chung, B Ovbiagele, KH Lee, et al.
  Year: 2011
  Citations: 364

• The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy
  Authors: PH Lee, G Lee, HJ Park, OY Bang, IS Joo, K Huh
  Year: 2006
  Citations: 311

• Collateral circulation in ischemic stroke: assessment tools and therapeutic strategies
  Authors: OY Bang, M Goyal, DS Liebeskind
  Year: 2015
  Citations: 305

🧾 Conclusion

Professor Oh Young Bang epitomizes excellence in translational neurology through his pioneering work in stroke research, neuroimaging, and stem cell-derived therapies. With a rare blend of academic leadership, clinical innovation, and industrial entrepreneurship, he represents a powerful force in the pursuit of solutions for some of medicine’s most intractable neurological challenges. His distinguished publications, editorial appointments, and patent portfolio collectively highlight his candidacy as a most deserving recipient of the Best Researcher Award.